Maria Concetta Cufaro
Overview
Explore the profile of Maria Concetta Cufaro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
327
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mattoscio D, Baeza L, Bai H, Colangelo T, Castagnozzi S, Marzotto M, et al.
FEBS J
. 2025 Mar;
PMID: 40029006
Cystic fibrosis (CF) is a genetic disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene, leading to chronic, unresolved inflammation of the airways due to uncontrolled recruitment...
2.
Di Marco F, Cufaro M, Damiani V, Dufrusine B, Pizzinato E, Di Ferdinando F, et al.
Oncogenesis
. 2025 Feb;
14(1):3.
PMID: 39956821
Pancreatic carcinoma (PC) is the sixth leading cause of cancer death in both sexes in 2022, responsible for almost 5% of all cancer deaths worldwide; it is characterized by a...
3.
Lanuti PhD P, Guardalupi F, Corradi PhD G, Florio PhD R, Brocco MD PhD D, Veschi PhD S, et al.
Blood Adv
. 2025 Feb;
PMID: 39903124
Chimeric Antigen Receptor (CAR) T cell-derived Extracellular Vesicles (EVs) might represent a new therapeutic tool for boosting CAR-T cell antileukemic effects. Here, a cohort of 22 patients infused with CD19.CAR-T...
4.
Kajimura Y, Tessari A, Orlacchio A, Thoms A, Cufaro M, Di Marco F, et al.
bioRxiv
. 2024 Jun;
PMID: 38826292
The biological functions of the scaffold protein Ran Binding Protein 9 (RanBP9) remain elusive in macrophages or any other cell type where this protein is expressed together with its CTLH...
5.
Piro A, Cufaro M, Lanuti P, Brocco D, De Lellis L, Florio R, et al.
Cancers (Basel)
. 2024 May;
16(10).
PMID: 38791876
Pancreatic cancer (PC) has a poor prognosis and displays resistance to immunotherapy. A better understanding of tumor-derived extracellular vesicle (EV) effects on immune responses might contribute to improved immunotherapy. EVs...
6.
Cufaro M, Prete R, Di Marco F, Sabatini G, Corsetti A, Gonzalez N, et al.
iScience
. 2024 Jan;
26(12):108481.
PMID: 38213792
Nowadays, Western diets and lifestyle lead to an increasing occurrence of chronic gut inflammation that represents an emerging health concern with still a lack of successful therapies. Fermented foods, and...
7.
Damiani V, Lamolinara A, Cicalini I, Cufaro M, Pizzo F, Di Marco F, et al.
Mol Metab
. 2023 Jun;
74:101752.
PMID: 37308077
Background: Insulin, secreted from pancreatic islets of Langerhans, is of critical importance in regulating glucose homeostasis. Defective insulin secretion and/or the inability of tissues to respond to insulin results in...
8.
Madonna R, Moscato S, Cufaro M, Pieragostino D, Mattii L, Del Boccio P, et al.
Cardiovasc Res
. 2023 Jan;
119(5):1175-1189.
PMID: 36627733
Aims: Sodium-glucose cotransporter 2 inhibitors have beneficial effects on heart failure and cardiovascular mortality in diabetic and non-diabetic patients, with unclear mechanisms. Autophagy is a cardioprotective mechanism under acute stress...
9.
Simeone P, Liani R, Tripaldi R, Ciotti S, Recchiuti A, Abbonante V, et al.
Haematologica
. 2022 Dec;
108(4):1141-1157.
PMID: 36546455
Cardiovascular (CV) disease prevention with low-dose aspirin can be less effective in patients with a faster recovery of platelet (PLT) cyclooxygenase (COX)-1 activity during the 24-hour dosing interval. We previously...
10.
Catitti G, Cufaro M, De Bellis D, Cicalini I, Vespa S, Tonelli F, et al.
Int J Mol Sci
. 2022 Dec;
23(23).
PMID: 36499243
Platelet-rich plasma (PRP) has great potential in regenerative medicine. In addition to the well-known regenerative potential of secreted growth factors, extracellular vesicles (EVs) are emerging as potential key players in...